Development of a highly potent, fully human anti-GM-CSF monoclonal antibody [ 2007 - 2007 ]

Research Grant

Researchers: Prof John Hamilton (Principal investigator) ,  John Schrader ,  Prof Gary Anderson

Brief description Many diseases, such as arthritis, have unwanted inflammatory reactions. Better drugs are needed to control inflammation. A powerful antibody to a significant pro-inflammatory cytokine will be generated; this antibody will be especially designed so that it will not be rejected by patients. Because of its properties it will cost the community less than similar therapeutics. Because inflammatory diseases are common many patients will benefit from our therapeutic.

Funding Amount $AUD 334,000.00

Funding Scheme NHMRC Development Grants

Notes Development Grant